BiondVax listed on the Tel Aviv Stock Exchange in June 2007, raising $3 million. The IPO included an issue of 3,530,000 ordinary shares and 350,000 warrants with a strike price of NIS 4.33.
On 8 December 2009, BiondVax executed a follow-on offering on the Tel Aviv Stock Exchange, raising $5.3 million. The offering included an issue of 5,000,000 shares and 1,250,000 warrants (Series 2) with a strike price of NIS 4.25.
Ordinary Shares
Symbol:
TASE: BNDX
Listing Venue:
Tel Aviv Stock Exhange (TASE)
ISIN:
IL0011052045
First Trading Day:
18 June 2007
Number of Shares Listed for Trading: (as at 25 February 2010)
34,702,023
Market Capitalization: (as at 25 February 2010)
NIS 112.8 mln
Warrants
Symbol:
TASE: BND.W1
Listing Venue:
Tel Aviv Stock Exhange (TASE)
ISIN:
IL0011054363
First Trading Day:
18 June 2007
Number of Warrants Listed for Trading: (as at 25 February 2010)
5,036,829
Market Capitalization: (as at 25 February 2010)
NIS 8.1 mln
Warrants
Symbol:
TASE: BND.W2
Listing Venue:
Tel Aviv Stock Exhange (TASE)
ISIN:
IL0011166159
First Trading Day:
13 December 2009
Number of Warrants Listed for Trading: (as at 25 February 2010)
